- 理想的成長型公司, 本業EPS的成長幅度會大於營收的成長幅度
- 營收到某個數字後, 本業EPS呈現不成比例的增加, 有可能是規模經濟的效應
- 如果是有淡旺季的公司, 是否有淡季不淡, 旺季更旺的情況
- 漲很多的股票要留意 EPS 較上季是否有大幅衰退的情況
- 如果EPS衰退，要觀察同業是不是有一樣的狀況
- 要留意增資減資和公司債對股本及EPS的影響
| 加權平均股數 QoQ YoY | EPS QoQ YoY | 本業EPS QoQ YoY | 累計EPS QoQ YoY | 營收 QoQ YoY | 毛利率(%) QoQ YoY | 營業利益 QoQ YoY | 稅後淨利 QoQ YoY | 稅前淨利率(%) QoQ YoY | 稅後淨利率(%) QoQ YoY | 兩季平均(YOY)營收成長率(%) | 兩季平均(YOY)EPS成長率(%) | 兩季平均(YOY)本業EPS成長率(%) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 23Q4 (20) | 32 | 0.0 | 0.0 | 1.02 | 337.21 | 191.43 | 1.03 | 294.34 | 232.26 | -0.44 | 69.86 | -438.46 | 0.97 | 125.58 | -1.02 | 79.63 | 9.02 | 33.09 | 0.35 | 450.0 | 250.0 | 0.33 | 335.71 | 200.0 | 35.81 | 298.5 | 224.07 | 33.59 | 206.43 | 193.36 | 76.03 | 171.86 | 136.94 |
| 23Q3 (19) | 32 | 0.0 | 0.0 | -0.43 | 6.52 | -7.5 | -0.53 | -20.45 | -12.77 | -1.46 | -41.75 | -563.64 | 0.43 | 26.47 | 7.5 | 73.04 | 2.4 | 2.34 | -0.1 | 41.18 | 28.57 | -0.14 | 6.67 | -7.69 | -18.04 | 66.61 | 42.73 | -31.56 | 27.83 | 2.68 | 18.07 | 12.91 | 2.49 |
| 23Q2 (18) | 32 | 0.0 | 0.0 | -0.46 | 19.3 | 32.35 | -0.44 | 25.42 | 33.33 | -1.03 | -80.7 | -672.22 | 0.34 | 9.68 | 0.0 | 71.33 | 4.33 | 7.34 | -0.17 | 22.73 | 19.05 | -0.15 | 16.67 | 31.82 | -54.03 | 18.81 | 14.74 | -43.73 | 24.42 | 31.44 | -29.35 | -121.78 | -132.45 |
| 23Q1 (17) | 32 | 0.0 | 0.0 | -0.57 | -262.86 | -166.28 | -0.59 | -290.32 | -167.05 | -0.57 | -538.46 | -166.28 | 0.31 | -68.37 | -85.38 | 68.37 | 14.27 | 93.9 | -0.22 | -320.0 | -168.75 | -0.18 | -263.64 | -164.29 | -66.55 | -702.26 | -550.58 | -57.86 | -605.33 | -545.08 | 38.31 | -37.68 | -62.18 |
| 22Q4 (16) | 32 | 0.0 | 6.67 | 0.35 | 187.5 | -52.05 | 0.31 | 165.96 | -47.46 | 0.13 | 159.09 | 117.81 | 0.98 | 145.0 | 13.95 | 59.83 | -16.17 | -16.0 | 0.1 | 171.43 | -47.37 | 0.11 | 184.62 | -50.0 | 11.05 | 135.08 | -56.2 | 11.45 | 135.31 | -54.36 | 81.33 | 114.34 | 97.38 |
| 22Q3 (15) | 32 | 0.0 | 3.23 | -0.40 | 41.18 | -33.33 | -0.47 | 28.79 | -51.61 | -0.22 | -222.22 | 85.33 | 0.4 | 17.65 | -14.89 | 71.37 | 7.4 | 6.16 | -0.14 | 33.33 | -40.0 | -0.13 | 40.91 | -44.44 | -31.50 | 50.29 | -56.72 | -32.43 | 49.15 | -64.54 | -33.16 | -68.94 | -73.11 |
| 22Q2 (14) | 32 | 0.0 | 14.29 | -0.68 | -179.07 | -4.62 | -0.66 | -175.0 | -32.0 | 0.18 | -79.07 | 114.75 | 0.34 | -83.96 | 0.0 | 66.45 | 88.46 | -6.72 | -0.21 | -165.62 | -23.53 | -0.22 | -178.57 | -22.22 | -63.37 | -529.05 | -13.26 | -63.78 | -590.62 | -18.15 | 31.27 | -80.63 | -62.92 |
| 22Q1 (13) | 32 | 6.67 | 14.29 | 0.86 | 17.81 | 250.88 | 0.88 | 49.15 | 204.76 | 0.86 | 217.81 | 250.88 | 2.12 | 146.51 | 657.14 | 35.26 | -50.5 | -30.66 | 0.32 | 68.42 | 218.52 | 0.28 | 27.27 | 275.0 | 14.77 | -41.46 | 124.88 | 13.00 | -48.19 | 122.49 | 114.75 | 180.57 | 169.73 |
| 21Q4 (12) | 30 | -3.23 | 7.14 | 0.73 | 343.33 | 15.87 | 0.59 | 290.32 | 18.0 | -0.73 | 51.33 | 32.41 | 0.86 | 82.98 | 11.69 | 71.23 | 5.95 | -2.1 | 0.19 | 290.0 | 5.56 | 0.22 | 344.44 | 22.22 | 25.23 | 225.52 | 0.6 | 25.09 | 227.3 | 9.56 | 60.61 | 198.59 | 164.16 |
| 21Q3 (11) | 31 | 10.71 | 10.71 | -0.30 | 53.85 | -11.11 | -0.31 | 38.0 | 24.39 | -1.50 | -22.95 | 12.28 | 0.47 | 38.24 | 9.3 | 67.23 | -5.63 | -9.77 | -0.1 | 41.18 | 16.67 | -0.09 | 50.0 | -12.5 | -20.10 | 64.08 | -13.24 | -19.71 | 63.49 | -5.46 | 29.84 | 19.91 | 39.24 |
| 21Q2 (10) | 28 | 0.0 | 0.0 | -0.65 | -14.04 | 34.34 | -0.50 | 40.48 | 45.05 | -1.22 | -114.04 | 15.28 | 0.34 | 21.43 | 13.33 | 71.24 | 40.1 | 10.33 | -0.17 | 37.04 | 41.38 | -0.18 | -12.5 | 35.71 | -55.95 | 5.76 | 41.02 | -53.98 | 6.63 | 42.81 | -21.11 | -102.26 | -113.76 |
| 21Q1 (9) | 28 | 0.0 | 0.0 | -0.57 | -190.48 | -29.55 | -0.84 | -268.0 | -170.97 | -0.57 | 47.22 | -29.55 | 0.28 | -63.64 | -56.92 | 50.85 | -30.11 | -12.94 | -0.27 | -250.0 | -92.86 | -0.16 | -188.89 | -33.33 | -59.37 | -336.72 | -150.4 | -57.81 | -352.45 | -206.03 | 7.71 | 71.42 | -23.03 |
| 20Q4 (8) | 28 | 0.0 | 0.0 | 0.63 | 333.33 | -36.36 | 0.50 | 221.95 | -35.9 | -1.08 | 36.84 | -111.76 | 0.77 | 79.07 | -30.0 | 72.76 | -2.35 | 1.66 | 0.18 | 250.0 | -30.77 | 0.18 | 325.0 | -35.71 | 25.08 | 241.3 | -4.2 | 22.90 | 222.53 | -9.05 | 61.20 | 203.03 | 138.45 |
| 20Q3 (7) | 28 | 0.0 | 0.0 | -0.27 | 72.73 | 67.86 | -0.41 | 54.95 | 37.88 | -1.71 | -18.75 | -14.0 | 0.43 | 43.33 | 34.38 | 74.51 | 15.39 | 2.97 | -0.12 | 58.62 | 45.45 | -0.08 | 71.43 | 66.67 | -17.75 | 81.29 | 76.58 | -18.69 | 80.2 | 74.63 | -5.26 | -26.13 | -69.30 |
| 20Q2 (6) | 28 | 0.0 | 0.0 | -0.99 | -125.0 | -280.77 | -0.91 | -193.55 | -468.75 | -1.44 | -227.27 | -118.18 | 0.3 | -53.85 | -34.78 | 64.57 | 10.55 | -12.21 | -0.29 | -107.14 | -314.29 | -0.28 | -133.33 | -300.0 | -94.86 | -300.08 | -400.32 | -94.38 | -399.63 | -506.56 | -47.38 | -134.72 | -166.65 |
| 20Q1 (5) | 28 | 0.0 | 0.0 | -0.44 | -144.44 | -10.0 | -0.31 | -139.74 | 0.0 | -0.44 | 13.73 | -10.0 | 0.65 | -40.91 | 38.3 | 58.41 | -18.39 | -27.18 | -0.14 | -153.85 | -27.27 | -0.12 | -142.86 | -9.09 | -23.71 | -190.57 | 9.71 | -18.89 | -175.02 | 21.13 | - | - | 0.00 |
| 19Q4 (4) | 28 | 0.0 | 0.0 | 0.99 | 217.86 | 0.0 | 0.78 | 218.18 | 0.0 | -0.51 | 66.0 | 0.0 | 1.1 | 243.75 | 0.0 | 71.57 | -1.09 | 0.0 | 0.26 | 218.18 | 0.0 | 0.28 | 216.67 | 0.0 | 26.18 | 134.55 | 0.0 | 25.18 | 134.18 | 0.0 | - | - | 0.00 |
| 19Q3 (3) | 28 | 0.0 | 0.0 | -0.84 | -223.08 | 0.0 | -0.66 | -312.5 | 0.0 | -1.50 | -127.27 | 0.0 | 0.32 | -30.43 | 0.0 | 72.36 | -1.62 | 0.0 | -0.22 | -214.29 | 0.0 | -0.24 | -242.86 | 0.0 | -75.78 | -299.68 | 0.0 | -73.67 | -373.46 | 0.0 | - | - | 0.00 |
| 19Q2 (2) | 28 | 0.0 | 0.0 | -0.26 | 35.0 | 0.0 | -0.16 | 48.39 | 0.0 | -0.66 | -65.0 | 0.0 | 0.46 | -2.13 | 0.0 | 73.55 | -8.3 | 0.0 | -0.07 | 36.36 | 0.0 | -0.07 | 36.36 | 0.0 | -18.96 | 27.8 | 0.0 | -15.56 | 35.03 | 0.0 | - | - | 0.00 |
| 19Q1 (1) | 28 | 0.0 | 0.0 | -0.40 | 0.0 | 0.0 | -0.31 | 0.0 | 0.0 | -0.40 | 0.0 | 0.0 | 0.47 | 0.0 | 0.0 | 80.21 | 0.0 | 0.0 | -0.11 | 0.0 | 0.0 | -0.11 | 0.0 | 0.0 | -26.26 | 0.0 | 0.0 | -23.95 | 0.0 | 0.0 | - | - | 0.00 |
| 年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024/3 | 0.11 | 41.61 | 6.37 | 0.27 | -14.13 | 0.27 | N/A | - | ||
| 2024/2 | 0.08 | -13.88 | -42.8 | 0.16 | -23.76 | 0.83 | N/A | - | ||
| 2024/1 | 0.09 | -86.92 | 6.87 | 0.09 | 6.87 | 0.94 | N/A | - | ||
| 2023/12 | 0.67 | 251.67 | -12.82 | 2.06 | -46.29 | 0.97 | 0.01 | 111年3月有醫學中心PACS建置案完工驗收 | ||
| 2023/11 | 0.19 | 63.92 | 67.14 | 1.39 | -54.64 | 0.46 | 0.02 | 111年3月有醫學中心PACS建置案完工驗收 | ||
| 2023/10 | 0.12 | -24.58 | 17.35 | 1.2 | -59.31 | 0.46 | 0.02 | 111年3月有醫學中心PACS建置案完工驗收 | ||
| 2023/9 | 0.15 | -18.4 | 0.71 | 1.09 | -61.96 | 0.43 | 0.09 | 111年3月有醫學中心PACS建置案完工驗收 | ||
| 2023/8 | 0.19 | 102.08 | 46.25 | 0.93 | -65.49 | 0.42 | 0.09 | 111年3月有醫學中心PACS建置案完工驗收 | ||
| 2023/7 | 0.09 | -34.84 | -19.1 | 0.75 | -71.07 | 0.32 | 0.12 | 111年3月有醫學中心PACS建置案完工驗收 | ||
| 2023/6 | 0.14 | 64.5 | 7.86 | 0.65 | -73.49 | 0.34 | 0.06 | 111年3 月有醫學中心PACS建置案完工驗收 | ||
| 2023/5 | 0.09 | -20.83 | -5.58 | 0.51 | -78.12 | 0.3 | 0.07 | 111年3月有醫學中心PACS建置案完工驗收 | ||
| 2023/4 | 0.11 | 9.64 | -7.74 | 0.42 | -81.1 | 0.34 | 0.06 | 111年3月有醫學中心PACS建置案完工驗收 | ||
| 2023/3 | 0.1 | -23.84 | -94.77 | 0.31 | -85.22 | 0.31 | 0.06 | 111年3月有醫學中心PACS建置案完工驗收 | ||
| 2023/2 | 0.13 | 60.9 | 37.29 | 0.21 | 5.12 | 0.98 | 0.02 | - | ||
| 2023/1 | 0.08 | -89.33 | -23.65 | 0.08 | -23.65 | 0.96 | 0.02 | - | ||
| 2022/12 | 0.77 | 574.29 | 45.64 | 3.84 | 96.92 | 0.98 | 0.01 | 本年有醫學中心PACS建置案完工驗收 | ||
| 2022/11 | 0.11 | 15.09 | -48.37 | 3.07 | 115.87 | 0.36 | 0.03 | 今年有醫學中心PACS建置案完工驗收 | ||
| 2022/10 | 0.1 | -35.27 | -15.54 | 2.96 | 145.91 | 0.38 | 0.03 | 本月有醫學中心PACS建置案完工驗收 | ||
| 2022/9 | 0.15 | 18.48 | -12.03 | 2.86 | 163.28 | 0.4 | 0.68 | 3月有醫學中心PACS建置案完工驗收 | ||
| 2022/8 | 0.13 | 11.77 | -3.37 | 2.71 | 196.56 | 0.38 | 0.72 | 3月有醫學中心PACS建置案完工驗收 | ||
| 2022/7 | 0.12 | -13.12 | -30.75 | 2.58 | 230.71 | 0.34 | 0.79 | 3月有醫學中心PACS建置案完工驗收 | ||
| 2022/6 | 0.13 | 43.99 | 21.29 | 2.46 | 301.58 | 0.34 | 0.29 | 3月有醫學中心PACS建置案完工驗收 | ||
| 2022/5 | 0.09 | -22.65 | -28.82 | 2.33 | 362.31 | 2.13 | 0.05 | 3月有醫學中心PACS建置案完工驗收 | ||
| 2022/4 | 0.12 | -93.79 | 22.89 | 2.24 | 497.21 | 2.13 | 0.05 | 上月有醫學中心PACS建置案完工驗收 | ||
| 2022/3 | 1.92 | 1902.44 | 2453.24 | 2.12 | 662.34 | 2.12 | 0.05 | 本月有醫學中心PACS建置案完工驗收 | ||
| 2022/2 | 0.1 | -10.52 | -2.23 | 0.2 | -0.11 | 0.73 | 0.14 | - | ||
| 2022/1 | 0.11 | -79.64 | 1.85 | 0.11 | 1.85 | 0.85 | 0.12 | - | ||
| 2021/12 | 0.53 | 139.0 | 29.35 | 1.95 | -9.47 | 0.86 | 1.41 | - | ||
| 2021/11 | 0.22 | 88.28 | 5.61 | 1.42 | -18.51 | 0.51 | 2.39 | - | ||
| 2021/10 | 0.12 | -32.58 | -24.4 | 1.2 | -21.78 | 0.42 | 2.88 | - | ||
| 2021/9 | 0.17 | 30.14 | -0.36 | 1.09 | -21.48 | 0.47 | 2.62 | - | ||
| 2021/8 | 0.13 | -19.89 | 23.69 | 0.91 | -24.52 | 0.41 | 3.03 | - | ||
| 2021/7 | 0.17 | 52.17 | 12.0 | 0.78 | -29.23 | 0.4 | 3.06 | - | ||
| 2021/6 | 0.11 | -15.5 | 8.1 | 0.61 | -35.65 | 0.34 | 3.61 | - | ||
| 2021/5 | 0.13 | 33.55 | 17.54 | 0.5 | -40.84 | 0.3 | 4.02 | - | ||
| 2021/4 | 0.1 | 28.93 | 10.0 | 0.38 | -49.49 | 0.27 | 4.48 | - | ||
| 2021/3 | 0.08 | -23.32 | -57.6 | 0.28 | -57.5 | 0.28 | 0.07 | 本年尚無大型專案驗收且海外市場業績衰退 | ||
| 2021/2 | 0.1 | -6.78 | 47.81 | 0.2 | -57.46 | 0.61 | 0.03 | 109年1月有大型專案驗收。 | ||
| 2021/1 | 0.11 | -74.15 | -74.43 | 0.11 | -74.43 | 0.72 | 0.03 | 109年1月有大型專案結案驗收。 | ||
| 2020/12 | 0.41 | 95.13 | -45.65 | 2.15 | -8.22 | 0.77 | 0.08 | - | ||
| 2020/11 | 0.21 | 34.77 | -20.03 | 1.75 | 9.28 | 0.54 | 0.11 | - | ||
| 2020/10 | 0.15 | -11.14 | 75.16 | 1.54 | 14.99 | 0.44 | 0.14 | 本月驗收結案合約較去年同期增加 | ||
| 2020/9 | 0.17 | 61.57 | 46.5 | 1.38 | 10.74 | 0.43 | 0.21 | - | ||
| 2020/8 | 0.11 | -27.46 | 2.32 | 1.21 | 6.99 | 0.36 | 0.25 | - | ||
| 2020/7 | 0.15 | 46.86 | 52.88 | 1.1 | 7.47 | 0.36 | 0.25 | 本月結案之合約金額較高 | ||
| 2020/6 | 0.1 | -8.12 | -62.51 | 0.95 | 2.72 | 0.3 | 0.1 | 本月無大型專案結案驗收 | ||
| 2020/5 | 0.11 | 24.99 | 24.49 | 0.85 | 29.43 | 0.38 | 0.08 | - | ||
| 2020/4 | 0.09 | -50.3 | -14.3 | 0.74 | 30.19 | 0.33 | 0.09 | - | ||
| 2020/3 | 0.18 | 167.31 | -38.77 | 0.65 | 39.97 | 0.65 | 0.06 | - | ||
| 2020/2 | 0.07 | -83.87 | -32.23 | 0.48 | 167.76 | 1.23 | 0.03 | 本年1月有大型專案結案驗收 | ||
| 2020/1 | 0.41 | -45.04 | 410.74 | 0.41 | 410.74 | 1.42 | 0.03 | 本月有大型專案完工驗收 | ||
| 2019/12 | 0.75 | 187.11 | 26.98 | 2.35 | 11.2 | 1.1 | 0.2 | - | ||
| 2019/11 | 0.26 | 195.21 | 74.06 | 1.6 | 5.08 | 0.47 | 0.47 | 10月遞延結案之合約於本期結案 | ||
| 2019/10 | 0.09 | -25.68 | -60.68 | 1.34 | -2.44 | 0.31 | 0.7 | 合約結案時程後延 | ||
| 2019/9 | 0.12 | 12.85 | 61.13 | 1.25 | 8.96 | 0.32 | 0.4 | 內外銷金額均較去年同期微幅成長 | ||
| 2019/8 | 0.11 | 8.37 | -40.22 | 1.13 | 5.37 | 0.47 | 0.28 | - | ||
| 2019/7 | 0.1 | -63.99 | -8.91 | 1.03 | 14.32 | 0.46 | 0.29 | - | ||
| 2019/6 | 0.27 | 205.13 | 26.87 | 0.93 | 17.46 | 0.46 | 0.07 | - | ||
| 2019/5 | 0.09 | -13.96 | -19.45 | 0.66 | 13.99 | 0.0 | N/A | - | ||
| 2019/4 | 0.1 | -64.49 | 15.79 | 0.57 | 21.84 | 0.0 | N/A | - |
| 加權平均股數 YoY | EPS YoY | 本業EPS YoY | 營收 YoY | 毛利率(%) YoY | 營業利益 YoY | 稅前淨利 YoY | 稅後淨利 YoY | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 (10) | 32 | 0.0 | -0.44 | 0 | -0.50 | 0 | 2.06 | -46.35 | 75.16 | 56.45 | -0.14 | 0 | -0.12 | 0 | -0.14 | 0 |
| 2022 (9) | 32 | 6.67 | 0.13 | 0 | 0.06 | 0 | 3.84 | 96.92 | 48.04 | -28.67 | 0.06 | 0 | 0.08 | 0 | 0.04 | 0 |
| 2021 (8) | 30 | 7.14 | -0.73 | 0 | -1.06 | 0 | 1.95 | -9.3 | 67.35 | -0.38 | -0.35 | 0 | -0.23 | 0 | -0.22 | 0 |
| 2020 (7) | 28 | 0.0 | -1.08 | 0 | -1.12 | 0 | 2.15 | -8.51 | 67.61 | -8.38 | -0.38 | 0 | -0.32 | 0 | -0.3 | 0 |
| 2019 (6) | 28 | 0.0 | -0.51 | 0 | -0.38 | 0 | 2.35 | 11.37 | 73.79 | -5.23 | -0.15 | 0 | -0.17 | 0 | -0.14 | 0 |
| 2018 (5) | 28 | 0.0 | -0.37 | 0 | -0.50 | 0 | 2.11 | 4.98 | 77.86 | 23.67 | -0.18 | 0 | -0.12 | 0 | -0.1 | 0 |
| 2017 (4) | 28 | 0.0 | -1.51 | 0 | -1.22 | 0 | 2.01 | -21.18 | 62.96 | 24.57 | -0.44 | 0 | -0.47 | 0 | -0.42 | 0 |
| 2016 (3) | 28 | 0.0 | -2.18 | 0 | -1.66 | 0 | 2.55 | -13.85 | 50.54 | -17.58 | -0.54 | 0 | -0.62 | 0 | -0.61 | 0 |
| 2015 (2) | 28 | 12.0 | -0.21 | 0 | -0.12 | 0 | 2.96 | 40.28 | 61.32 | -10.78 | 0.02 | 0 | 0 | 0 | -0.06 | 0 |
| 2014 (1) | 25 | 19.05 | -2.68 | 0 | -2.19 | 0 | 2.11 | -9.83 | 68.73 | 0 | -0.73 | 0 | -0.72 | 0 | -0.68 | 0 |
